Study of an injected treatment for moderate-to-severe atopic dermatitis
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests a new injected medication called XKH001 for people with moderate-to-severe atopic dermatitis (a type of eczema) that hasn't improved with standard creams. The goal is to see if it can reduce the severity of eczema and itching.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with atopic dermatitis (eczema) for at least 6 months.
- Your eczema is moderate to severe, meaning a doctor has scored it at a certain level (like an EASI score of 16 or more, and you have itchiness most days).
- You have tried prescription creams or ointments for eczema but they didn't work well enough, or you couldn't use them.
- You are willing to use a basic moisturizer (like a fragrance-free lotion) twice a day for at least a week before starting and during the study.
- You have not used certain other eczema treatments (like oral steroids, immunosuppressants, or biologic injections) within a few weeks or months before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injectable drug called SKB575 for people with moderate to severe atopic dermatitis (eczema). It aims to see how safe and effective the drug is, especially for those who haven't had success with strong creams or pills.
This trial tests an experimental medicine called QX-4533. The study has two parts: one tests the drug in healthy volunteers, and the other tests it in people with moderate-to-severe atopic dermatitis (a type of eczema) that hasn't responded well to standard creams. The goal is to see if the drug is safe and how well it works.
This trial tests an investigational drug called BxC-I17e, given as an injection under the skin, for people with moderate to severe atopic dermatitis (eczema) that hasn't improved enough with standard creams. The goal is to see if it is safe and works well.
This study tests a new injectable medication called MG-K10 for people with moderate to severe atopic dermatitis (eczema). The goal is to see if it reduces itching and clears skin better than a placebo. If you've tried topical treatments without enough relief, this might be an option.
This study tests an injection called ADSTEM for people with moderate to severe eczema (atopic dermatitis) that hasn't improved with standard creams or other treatments. The goal is to see if it can help reduce symptoms like itching and rash.
This study tests an investigational cream for moderate to severe eczema. It helps see if the cream reduces symptoms like itching and skin inflammation.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.